Subscribe To
VBLT / Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q4 2021 Results - Earnings Call Transcript
VBLT News
By PennyStocks
April 19, 2023
Penny Stocks To Buy? 10 Under $1 To Watch This Week
Penny stocks under $1 to watch this week. The post Penny Stocks To Buy? more_horizontal
By PennyStocks
April 17, 2023
Penny Stocks To Buy? 7 Under $1 To Watch This Week
Penny stocks to watch trading for pennies this week. The post Penny Stocks To Buy? more_horizontal
By PennyStocks
March 1, 2023
Penny Stocks To Buy: 5 To Watch Before Next Week
Penny stocks to watch this week. The post Penny Stocks To Buy: 5 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Info more_horizontal
By InvestorPlace
February 23, 2023
Why Is Vascular Biogenics (VBLT) Stock Up 52%?
Vascular Biogenics (NASDAQ: VBLT ) stock is rocketing higher on Thursday following news of a merger with Notable Labs. The details of the deal include more_horizontal
By Benzinga
July 20, 2022
Why Vascular Biogenics Stock Is Plunging
Vascular Biogenics Ltd (NASDAQ: VBLT) shares are falling Wednesday after the company announced that the data from its Phase 3 OVAL trial of ofra-vec more_horizontal
By Zacks Investment Research
May 17, 2022
Vascular Biogenics (VBLT) Reports Q1 Loss, Misses Revenue Estimates
Vascular Biogenics (VBLT) delivered earnings and revenue surprises of -8.33% and 42.35%, respectively, for the quarter ended March 2022. Do the number more_horizontal
By Seeking Alpha
March 23, 2022
Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q4 2021 Results - Earnings Call Transcript
Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q4 2021 Results - Earnings Call Transcript more_horizontal
By GlobeNewsWire
March 14, 2022
UPDATE -- VBL Therapeutics to Report Year-End 2021 Financial Results on March 23
TEL AVIV, Israel and NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a late-clinical stage biotechnology company focused more_horizontal